Media stories about NanoString Technologies (NASDAQ:NSTG) have been trending somewhat positive on Friday, Accern reports. The research group identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. NanoString Technologies earned a daily sentiment score of 0.17 on Accern’s scale. Accern also assigned media stories about the biotechnology company an impact score of 47.7563809679067 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Here are some of the news articles that may have effected Accern Sentiment’s rankings:
- Leading Researchers in Cancer Immunotherapy and Biosciences to Collaborate in Novel Two-Day Workshops Hosted by the Society for Immunotherapy of Cancer (prweb.com)
- NanoString Technologies (NSTG) Given Average Recommendation of “Hold” by Brokerages (americanbankingnews.com)
- -$0.77 Earnings Per Share Expected for NanoString Technologies (NSTG) This Quarter (americanbankingnews.com)
- NanoString Technologies (NSTG) Upgraded to “Hold” at Zacks Investment Research (americanbankingnews.com)
NASDAQ:NSTG opened at $7.87 on Friday. The company has a market cap of $187.75, a price-to-earnings ratio of -4.28 and a beta of 0.75. The company has a debt-to-equity ratio of 1.22, a current ratio of 3.40 and a quick ratio of 2.84. NanoString Technologies has a twelve month low of $5.87 and a twelve month high of $20.16.
NSTG has been the subject of a number of recent research reports. Zacks Investment Research raised NanoString Technologies from a “hold” rating to a “buy” rating and set a $8.25 price target for the company in a research report on Wednesday, January 3rd. Morgan Stanley reaffirmed an “equal weight” rating and set a $12.00 price target (down previously from $13.00) on shares of NanoString Technologies in a research report on Thursday, March 8th. Finally, ValuEngine downgraded NanoString Technologies from a “sell” rating to a “strong sell” rating in a research report on Friday, February 2nd. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. NanoString Technologies has a consensus rating of “Hold” and an average price target of $13.06.
In related news, Director William Young acquired 30,000 shares of the business’s stock in a transaction dated Tuesday, March 13th. The stock was bought at an average price of $6.91 per share, with a total value of $207,300.00. Following the acquisition, the director now owns 30,000 shares in the company, valued at approximately $207,300. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 24.40% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “NanoString Technologies (NASDAQ:NSTG) Receiving Somewhat Positive News Coverage, Accern Reports” was originally published by BBNS and is the sole property of of BBNS. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://baseballnewssource.com/2018/04/06/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-nanostring-technologies-nstg-share-price/2029779.html.
About NanoString Technologies
NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.